Definitive Contract 75F40120C00070
Award Date 8/21/20
Potential Completion Date 12/28/22
Potential Value $832K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Austria
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Research Center Pharmaceutical Engineering GMBH (RCPE) has been awarded a definitive cost no fee contract from the U.S. Department of Health and Human Services Food and Drug Administration (FDA). With a potential value of $1,256,778, this contract is to provide precision modeling tools for evaluating continuous manufacturing control approaches through a high-fidelity digital twin for industry and FDA use. RCPE will deliver its services in Austria, with Technische Universitaet Graz (TU Graz)...
- The U.S. Food and Drug Administration (FDA) awarded a $515,769.89 firm fixed price definitive contract to the University of St. Gallen, a Swiss educational institution, to conduct research and develop tools to strengthen post-market surveillance of FDA-regulated products. The objective is to apply advanced analytics and hybrid artificial intelligence to improve risk identification. This contract was awarded under the FDA's Fiscal Year 2025 Broad Agency Announcement (BAA) for Advanced Research...
- The U.S. Food and Drug Administration (FDA) awarded a $120,950.00 firm fixed-price purchase order contract to Tissuse GMBH, a for-profit organization based in Germany. The contract is for the development of a multi-organ human-on-a-chip system, with a period of performance ending on December 31, 2024. The contract does not have a set-aside designation. Based on the FDA's role in evaluating medical technologies, this contract is likely related to the agency's efforts to advance the development of...
- The Department of Health and Human Services Food and Drug Administration awarded a $906,628.80 firm fixed price definitive contract to Universitat ST. Gallen, doing business as Hochschule Für Wirtschafts-, Rechts- und Sozialwissenschaften, to address the Broad Agency Announcement FY23C2DWP1: Predictive Continuous Improvement Acceleration towards Performance Based Regulations and Oversight. The contract responds to the FY23 FDA Broad Agency Announcement for Advanced Research and Development of...
- This is a $1,904,355.00 definitive cost-no-fee contract awarded by the Food and Drug Administration (FDA), a civilian government agency, to the Institute Of Quantitative Systems Pharmacology, a non-profit organization. The contract is for basic and applied research with two key objectives: (1) to test the hypothesis that variabilities in nanoparticle (NP) properties and tumor targets cause uncertainties in "FORMULA", and (2) to develop computational models to predict the...
- This is a $1,387,320.00 firm fixed price delivery order awarded by the Food and Drug Administration (FDA) to Research Triangle Institute (RTI International), a non-profit research organization. The contract is for evaluating differences in High Performance Hybrid Composite (HPHC) yield due to hardware changes resulting from long-term end use. This work supports the FDA's regulatory responsibilities. The contract does not have a set-aside designation. RTI International has received other...
- The U.S. Food and Drug Administration (FDA) awarded a Firm Fixed Price Delivery Order contract worth $139,704.00 to Research Triangle Institute (RTI International), a non-profit research organization, for an "ECON CHARACTERIZATION OF INDUSTRY SURVEY OF CURRENT MANUFACTURING PRACTICES AND COST OF IMPLEMENTING GOOD MANUFACTURING PRACTICES FOR THE COSMETICS INDUSTRY" as part of the larger "ECONOMIC STUDIES OF FDA REGULATIONS" program. The contract has a final completion date...
- This federal contract award was issued by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Vitrocell Systems GMBH, a foreign-owned limited liability company based in Germany. The $611,231.64 firm-fixed-price purchase order is for a "HIGH TEMP SPIKING SYSTEM WITH POST-WARRANTY PREVENTATIVE MAINTENANCE OPTIONS" to support the FDA's research, testing, and evaluation programs. Vitrocell Systems GMBH is a manufacturer of...
- The Department of Health and Human Services Food and Drug Administration awarded a $324,203.60 delivery order to Koniag Management Solutions LLC under an unspecified contract vehicle. The order is to provide two junior researchers to act as a pharmaceutical development and manufacturing specialist and as a reaction chemistry and separation specialist at the prime contractor's place of performance in Silver Spring, Maryland. The period of performance is from September 27, 2021 through September...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $4,122,028.80 delivery order contract to Koniag Management Solutions LLC to obtain eight scientific contract professionals to support the research program of the FDA's Center for Drug Evaluation and Research, Office of Biotechnology Products. The contract is for a base period of performance from June 24, 2022 to June 26, 2025 in Silver Spring, Maryland and utilizes a labor hours pricing structure.